Selective small-molecule inhibition of an RNA structural element
The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Riboswitches are non-coding RNA structures located in messenger RNAs that bind endogenous ligands, such as a specific metabolite or ion, to regulate gene expression. As such, riboswitches serve as a novel, yet largely unexploited, class of emerging drug targets. Demonstrating this potential, however, has proven difficult and is restricted to structurally similar antimetabolites and semi-synthetic analogues of their cognate ligand, thus greatly restricting the chemical space and selectivity sought for such inhibitors. Here we report the discovery and characterization of ribocil, a highly selective chemical modulator of bacterial riboflavin riboswitches, which was identified in a phenotypic screen and acts as a structurally distinct synthetic mimic of the natural ligand, flavin mononucleotide, to repress riboswitch-mediated ribB gene expression and inhibit bacterial cell growth. Our findings indicate that non-coding RNA structural elements may be more broadly targeted by synthetic small molecules than previously expected.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Ribocil binding inhibits translation of ribB transcript in E. coli, inducing cell death by riboflavin starvation.”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [123]
In the citing paper
“a high throughput screening of small molecules recently identified an inhibitor of riboflavin synthesis, called “ribocil”, that targets a regulatory non-coding region (i.e. riboswitch) in the mRNA of a synthase involved in the pathway, ribB [123].”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [123]
In the citing paper
“ribocil administration, although only at high concentrations, significantly reduced bacterial burden in a mouse model of systemic infection with E. coli”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [123]
Citations
Cites
Features and development of Coot
Emsley, P., Lohkamp, B., Scott, W. G., & Cowtan, K. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444910007493 · Cited by 29,915
PHENIX : a comprehensive Python-based system for macromolecular structure solution
Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L.-W., Kapral, G. J., Grosse-Kunstleve, R. W., et al. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909052925 · Cited by 23,716
Kabsch, W. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909047337 · Cited by 16,463
One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products
Datsenko, K. A., & Wanner, B. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.120163297 · Cited by 14,782
Construction of Escherichia coli K‐12 in‐frame, single‐gene knockout mutants: the Keio collection
Baba, T., Ara, T., Hasegawa, M., Takai, Y., Okumura, Y., Baba, M., Datsenko, K. A., Tomita, M., Wanner, B. L., & Mori, H. (2006) · Molecular Systems Biology · doi:10.1038/msb4100050 · Cited by 7,858
PHENIX: a comprehensive Python-based system for macromolecular structure solution
Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L.-W., Kapral, G. J., Grosse-Kunstleve, R. W., et al. (2012) · International Tables for Crystallography · doi:10.1107/97809553602060000865 · Cited by 7,334
Landscape of transcription in human cells
Djebali, S., Davis, C. A., Merkel, A., Dobin, A., Lassmann, T., Mortazavi, A., Tanzer, A., Lagarde, J., Lin, W., Schlesinger, F., et al. (2012) · Nature · doi:10.1038/nature11233 · Cited by 5,187
Self-citationBad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D., Rice, L. B., Scheld, M., Spellberg, B., & Bartlett, J. (2009) · Clinical Infectious Diseases · doi:10.1086/595011 · Cited by 4,958
How good are my data and what is the resolution?
Evans, P. R., & Murshudov, G. N. (2013) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444913000061 · Cited by 4,697
Functional Characterization of the S. cerevisiae Genome by Gene Deletion and Parallel Analysis
Winzeler, E. A., Shoemaker, D. D., Astromoff, A., Liang, H., Anderson, K., Andre, B., Bangham, R., Benito, R., Boeke, J. D., Bussey, H., et al. (1999) · Science · doi:10.1126/science.285.5429.901 · Cited by 3,953
Research works printed but not linked: 2
- Kodali, S. et al. Determination of selectivity and efficacy of fatty acid synthesis inhibitors. J. Biol. Chem. 280, 1669–1677 (2005) · DOI
- Bricogne, G. et al. BUSTER version 2.11.5 http://www.globalphasing.com (2014)
Cited by
Items 201–300 of 406
Dutta, D., & Wedekind, J. E. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010755 · Cited by 17
“molecules that control essential genes makes riboswitches ideal candidates for drug development (10-18).”
BackgroundBase-intercalated and base-wedged stacking elements in 3D-structure of RNA and RNA–protein complexes
Baulin, E. F., Metelev, V., & Bogdanov, A. A. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa610 · Cited by 17
“(32) devised an RNA aptamer consisting of two polynucleotide segments.”
BackgroundA toolkit for the identification of NEAT1_2/paraspeckle modulators
An, H., Elvers, K. T., Gillespie, J. A., Jones, K. M., Atack, J. R., Grubisha, O., & Shelkovnikova, T. A. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac771 · Cited by 20
“Ribocil, which binds to riboflavin riboswitches (56), had no effect on either RNA (Figure 2C).”
BackgroundLarge-scale analysis of small molecule-RNA interactions using multiplexed RNA structure libraries
Nagasawa, R., Onizuka, K., Komatsu, K. R., Miyashita, E., Murase, H., Ojima, K., Ishikawa, S., Ozawa, M., Saito, H., & Nagatsugi, F. (2024) · Communications Chemistry · doi:10.1038/s42004-024-01181-8 · Cited by 19
“6,7 Further, human precursor microRNAs (pre-miRNAs) 8–13 , various repetitive RNAs, such as CUG 14–17 and UGGAA 18 repeats, and structured RNA elements of infectious pathogens 19–21 are considered promising drug targets.”
RNA folding kinetics control riboswitch sensitivity in vivo
Bushhouse, D. Z., Fu, J., & Lucks, J. B. (2025) · Nature Communications · doi:10.1038/s41467-024-55601-3 · Cited by 19
Kenderdine, T., & Fabris, D. (2021) · Mass Spectrometry Reviews · doi:10.1002/mas.21766 · Cited by 18
Alternative RNA Conformations: Companion or Combatant
Gupta, P., Khadake, R. M., Panja, S., Shinde, K., & Rode, A. B. (2022) · Genes · doi:10.3390/genes13111930 · Cited by 16
Comparative genomics and phylogenomic analyses of lysine riboswitch distributions in bacteria
Mukherjee, S., Barash, D., & Sengupta, S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184314 · Cited by 18
Väre, V. Y. P., Schneider, R. F., Kim, H., Lasek‐Nesselquist, E., McDonough, K. A., & Agris, P. F. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01247-20 · Cited by 15
“One promising target for drug discovery is that of riboswitches, with several drug discovery platforms already being established for targeting them (12, 13).”
Silver, L. L. (2017) · Topics in medicinal chemistry · doi:10.1007/7355_2017_24 · Cited by 19
Eukaryotic Ribosomal Expansion Segments as Antimicrobial Targets
Ramos, L. M. G., Degtyareva, N. N., Kovacs, N. A., Holguin, S. Y., Jiang, L., Petrov, A. S., Biesiada, M., Hu, M. Y., Purzycka, K. J., Arya, D. P., et al. (2017) · Biochemistry · doi:10.1021/acs.biochem.7b00703 · Cited by 17
Molecular mechanisms for dynamic regulation of N1 riboswitch by aminoglycosides
Kulik, M., Mori, T., Sugita, Y., & Trylska, J. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky833 · Cited by 15
“for the bacterial riboflavin riboswitch (11).”
Hu, G., & Zhou, H. (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1009603 · Cited by 14
Targeting Riboswitches with Beta-Axial-Substituted Cobalamins
Lennon, S. R., Wierzba, A. J., Siwik, S. H., Gryko, D., Palmer, A. E., & Batey, R. (2023) · ACS Chemical Biology · doi:10.1021/acschembio.2c00939 · Cited by 17
RNA Regulators: Formidable Modulators of Yersinia Virulence
Nuss, A. M., Heroven, A. K., & Dersch, P. (2016) · Trends in Microbiology · doi:10.1016/j.tim.2016.08.006 · Cited by 14
“compounds, or RNAs that interfere with the essential LcrF thermometer, similar to the recently developed riboswitch inhibitors [65, 66].”
Rapid Inhibition Profiling Identifies a Keystone Target in the Nucleotide Biosynthesis Pathway
Peters, C. E., Lamsa, A., Liu, R. B., Quach, D., Sugie, J., Brumage, L., Pogliano, J., López‐Garrido, J., & Pogliano, K. (2018) · ACS Chemical Biology · doi:10.1021/acschembio.8b00273 · Cited by 16
Modulating RNA secondary and tertiary structures by mismatch binding ligands
Murata, A., Nakamori, M., & Nakatani, K. (2019) · Methods · doi:10.1016/j.ymeth.2019.05.006 · Cited by 17
Mining for Ligandable Cavities in RNA
Xie, J., & Frank, A. T. (2021) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.1c00068 · Cited by 15
An in vivo high-throughput screening for riboswitch ligands using a reverse reporter gene system
Kirchner, M., Schorpp, K., Hadian, K., & Schneider, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-07870-w · Cited by 16
Bush, J. A., Williams, C. C., Meyer, S. M., Tong, Y., Haniff, H. S., Childs‐Disney, J. L., & Disney, M. D. (2021) · ACS Chemical Biology · doi:10.1021/acschembio.1c00014 · Cited by 14
Perkins, K. R., Atilho, R. M., Moon, M. H., & Breaker, R. R. (2019) · ACS Chemical Biology · doi:10.1021/acschembio.9b00713 · Cited by 14
“Such riboswitch-targeting screens have been described previously (Blount et al., 2006; Mayer and Famulok, 2006; Hickey and Hammond, 2014; Howe et al., 2015; Kirchner et al. 2017).”
BackgroundDiscovery of RNA‐Targeting Small Molecules: Challenges and Future Directions
Cai, Z., Ma, H., Ye, F., Lei, D., Deng, Z., Li, Y., Gu, R., & Wen, H. (2025) · MedComm · doi:10.1002/mco2.70342 · Cited by 20
“Crystallographic studies have revealed that only one isomer ((S)-Ribocil-B) of racemic Ribocil mixtures binds to the RNA in a U-shaped conformation, interacting with specific bases and demonstrating additional stacking interactions compared with FMN [60].”
RPflex: A Coarse-Grained Network Model for RNA Pocket Flexibility Study
Chen, Z., Zeng, C., Rui, Y., Liu, H., & Zhao, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065497 · Cited by 13
Fullenkamp, C. R., Mehdi, S., Jones, C. P., Tenney, L., Pichling, P., Prestwood, P. R., Ferré-D’Amaré, A. R., Tiwary, P., & Schneekloth, J. S. (2025) · Angewandte Chemie International Edition · doi:10.1002/anie.202505971 · Cited by 14
LncRNAs in Adipose Tissue from Obese and Insulin-Resistant Subjects: New Targets for Therapy?
Latorre, J., & Fernández‐Real, J. M. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.03.023 · Cited by 13
“In 2015, Howe and colleagues described a synthetic small molecule selectively targeting the specific non-coding RNA structure, so non-coding RNA structural elements could be more broadly targeted than expected (Howe et al., 2015).”
BackgroundLin, X., Luo, M., & Song, E. (2022) · Cell Insight · doi:10.1016/j.cellin.2022.100004 · Cited by 15
DNA‐Encoded Libraries and Their Application to RNA
Yang, X., Childs‐Disney, J. L., Paegel, M., & Disney, M. D. (2023) · Israel Journal of Chemistry · doi:10.1002/ijch.202300073 · Cited by 13
Better living through chemistry: Addressing emerging antibiotic resistance
Coussens, N. P., Molinaro, A. L., Culbertson, K. J., Peryea, T., Zahoránszky-Köhalmi, G., Hall, M. D., & Daines, D. A. (2018) · Experimental Biology and Medicine · doi:10.1177/1535370218755659 · Cited by 17
“coli bacterial burden in a mouse model of septicemia by two to three orders of magnitude.(92) While further research on riboswitches as drug targets is warranted, caveats include the potential for gain of mutations as well as the observed difficulty for some modulators to cross the bacterial cell wall.”
Drug Design of “Undruggable” Targets
Wang, J., Li, S., & Li, H. (2019) · Chinese Journal of Chemistry · doi:10.1002/cjoc.201800552 · Cited by 13
A guide to RNA structure analysis and RNA ‐targeting methods
Aguilar, R., Mardones, C., Moreno, A. A., & Cepeda‐Plaza, M. (2024) · FEBS Journal · doi:10.1111/febs.17368 · Cited by 17
“A notable example of a serendipitous discovery of an RNA-targeting drug is ribocil, identified by researchers at Merck Research Laboratories [84].”
Ansari, N., Liu, C., Hédin, F., Hénin, J., Ponder, J. W., Ren, P. Y., Piquemal, J., Lagardère, L., & Hage, K. E. (2025) · Communications Biology · doi:10.1038/s42003-025-08809-y · Cited by 20
“These molecules modulate diverse biological processes,suchasinhibitingbacterialandviraltranslation(e.g.,ribocilanda riboswitchin Escherichia coli 9 , 2-aminobenzimidazole derivatives and the hepatitisCinternalribosomeentrysite(IRES) 10 ,respectively),anddirecting…”
Seyler, T. M., Moore, C., Kim, H., Ramachandran, S., & Agris, P. F. (2021) · Antibiotics · doi:10.3390/antibiotics10010041 · Cited by 12
Antibacterial New Target Discovery: Sentinel Examples, Strategies, and Surveying Success
Sutterlin, H. A., Malinverni, J. C., Lee, S. H., Balibar, C. J., & Roemer, T. (2017) · Topics in medicinal chemistry · doi:10.1007/7355_2016_31 · Cited by 13
Self-citationYu, J., Feng, Q., Zheng, J., Liu, H., Liu, H., Zhou, R., Jiang, X., Yan, H., Liang, Z., Chen, M., et al. (2025) · Advanced Materials · doi:10.1002/adma.202515338 · Cited by 12
Hermann, T. (2015) · Nature · doi:10.1038/nature15635 · Cited by 11
Targeting RNA with small molecules—A safety perspective
Lightfoot, H. L., & Smith, G. F. (2023) · British Journal of Pharmacology · doi:10.1111/bph.16027 · Cited by 11
Targeting RNA with small molecules: lessons learned from Xist RNA
Nickbarg, E. B., Spencer, K. B., Mortison, J. D., & Lee, J. T. (2023) · RNA · doi:10.1261/rna.079523.122 · Cited by 11
“Initial application of the ALIS AS-MS platform to screening noncoding RNAs used the FMN bacterial riboswitch as a model system, since this target had known drug-like active binders (Howe et al. 2015; Rizvi et al. 2018).”
InfluentialStructure-Based Discovery of Small Molecules Binding to RNA
Wehler, T., & Brenk, R. (2017) · Topics in medicinal chemistry · doi:10.1007/7355_2016_29 · Cited by 11
Chemical genomics reveals mechanistic hypotheses for uncharacterized bioactive molecules in bacteria
French, S., Ellis, M. J., Coutts, B. E., & Brown, E. D. (2017) · Current Opinion in Microbiology · doi:10.1016/j.mib.2017.09.005 · Cited by 11
Modeling ligand docking to RNA in the design of RNA-based nanostructures
Kasprzak, W. K., Ahmed, N. A., & Shapiro, B. A. (2019) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2019.10.010 · Cited by 11
Chou, W. K., Vaikunthan, M., Schröder, H. V., Link, A. J., Kim, H., & Brynildsen, M. P. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.01001 · Cited by 11
“Use of such mutants in chemical screening has been done previously (Howe et al., 2015).”
BackgroundSmall RNAs in Bacterial Virulence and Communication
Svensson, S. L., & Sharma, C. M. (2016) · ASM Press eBooks · doi:10.1128/9781555819286.ch7 · Cited by 16
Stacking Interactions of Druglike Heterocycles with Nucleobases
Conner, A. V., Kim, L. M., Fagan, P., Harding, D. P., & Wheeler, S. E. (2025) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.4c02420 · Cited by 10
Conformational dynamics and energetics of viral RNA recognition by lab-evolved proteins
Kumar, A., & Vashisth, H. (2021) · Physical Chemistry Chemical Physics · doi:10.1039/d1cp03822b · Cited by 10
Zhu, Q., Lin, Q., Jiang, Y., Chen, S., Tian, J., Yang, S., Li, Y., Li, M., Wang, Y., Shen, C., et al. (2023) · Applied and Environmental Microbiology · doi:10.1128/aem.00956-23 · Cited by 13
“RibB, 3,4-dihydroxy-2-butanone 4-phosphate synthase encoded by ribB (KPN_03454), contributed the virulence of E. coli in a murine septicemia model (50).”
Armstrong, I., Aldhumani, A. H., Schopis, J. L., Fang, F., Parsons, E., Zeng, C., Hossain, M. I., Bergmeier, S. C., & Hines, J. V. (2020) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2020.115696 · Cited by 10
Role of conformational heterogeneity in ligand recognition by viral RNA molecules
Levintov, L., & Vashisth, H. (2021) · Physical Chemistry Chemical Physics · doi:10.1039/d1cp00679g · Cited by 10
Reporter Gene-Based Screening for TPP Riboswitch Activators
Weinberg, C. E., & Mayer, G. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6634-9_13 · Cited by 11
Selective recognition of HIV RNA by dinuclear metallic ligands
Li, X., Chen, B., Lan, L., Wang, R., Luo, D., Liu, L., & Cheng, L. (2018) · Chinese Chemical Letters · doi:10.1016/j.cclet.2018.06.003 · Cited by 9
Designing small molecules targeting a cryptic RNA binding site through base displacement
Olenginski, L. T., Wierzba, A. J., Laursen, S. P., & Batey, R. (2025) · Nature Chemical Biology · doi:10.1038/s41589-025-02018-8 · Cited by 9
“For example, BioRelix 9,10 and Merck 11,12 have reported promising lead compounds against the FMN riboswitch that demonstrate efficacy in animal models.”
Yuan, B., Tang, Y., Yan, L., Chen, X., Geng, B., Zhao, Y., & Shi, J. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03871-4 · Cited by 9
“In clinical practice, conventional antimicrobial approaches often demonstrate limited efficacy in eliminating established biofilms, necessitating repeated surgical interventions [15–17].”
Using Selectively Scaled Molecular Dynamics Simulations to Assess Ligand Poses in RNA Aptamers
Liu, Y., & Frank, A. T. (2022) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.2c00123 · Cited by 9
Wu, Z., Wu, Q., Yuan, W., Chen, Y., Hu, D., Deng, D., Zhang, L.-L., & Niu, X. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.04051-22 · Cited by 9
Kinetic FRET Assay to Measure Binding-Induced Conformational Changes of Nucleic Acids
Higuera-Rodríguez, R. A., Pascali, M. C. D., Aziz, M., Sattler, M., Rant, U., & Kaiser, W. (2023) · ACS Sensors · doi:10.1021/acssensors.3c01527 · Cited by 9
Molecular insights into de novo small-molecule recognition by an intron RNA structure
Liu, T., Xu, L., Chung, K., Sisto, L. J., Hwang, J., Zhang, C., Zandt, M. C. V., & Pyle, A. M. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2502425122 · Cited by 12
“The large size of functionally relevant RNA molecules and RNA complexes limits the utility of X - ray crystallography, and therefore only small RNA molecules and isolated domains tend to be amenable to this approach ( 5 , 14 – 19 ).”
InfluentialXia, Y., Hu, J., Qiu, J., Wang, P., Li, L., Xu, S., Geng, B., Pan, S., & Fu, Q. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.172210 · Cited by 8
Dynamical characterization and multiple unbinding paths of two PreQ 1 ligands in one pocket
Hu, G., Zhang, Y., Yu, Z., Cui, T., & Cui, W. (2023) · Physical Chemistry Chemical Physics · doi:10.1039/d3cp03142j · Cited by 8
Target engagement approaches for pharmacological evaluation in animal models
Kath, J. E., & Baranczak, A. (2019) · Chemical Communications · doi:10.1039/c9cc02824b · Cited by 8
Berdnikova, D. V., Carloni, P., Krauß, S., & Rossetti, G. (2021) · Molecules · doi:10.3390/molecules26113384 · Cited by 9
“The latter is crucial to identify binding pockets that can be exploited for drug design [110].”
BackgroundLi, J., Valkenburgh, J. S. V., Fang, J., Zhang, D., Chen, Y., Chen, Q., Jia, G., Chen, A. Z., Zhang, X., & Chen, K. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106395 · Cited by 8
Arnau, G. V., Danilovich, M. E., Sánchez, L. A., Acosta, F., & Delgado, O. D. (2016) · Springer eBooks · doi:10.1007/978-3-319-42801-7_8 · Cited by 8
Two Are Better Than One: Dual Targeting of Riboswitches by Metabolite Analogs
Krajewski, S. S., Ignatov, D., & Johansson, J. (2017) · Cell chemical biology · doi:10.1016/j.chembiol.2017.05.004 · Cited by 8
Antibiotics: Precious Goods in Changing Times
Saß, P. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6634-9_1 · Cited by 11
Path-Based Nonequilibrium Binding Free Energy Estimation, from Protein–Ligand to RNA-Ligand Binding
Serra, E., Ghidini, A., Aguti, R., Bernetti, M., Decherchi, S., & Cavalli, A. (2025) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5c00452 · Cited by 10
Ichijo, R., Kamimura, T., & Kawai, G. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1145528 · Cited by 7
“Many kinds of druglike small compounds such as ribocil (Howe et al., 2015) and branaplam (Palacino et al.”
BackgroundKersten, C., Archambault, P., & Köhler, L. P. (2024) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.4c00520 · Cited by 7
Biophysical Approaches to Bacterial Gene Regulation by Riboswitches
Pérez‐González, C., Grondin, J. P., Lafontaine, D. A., & Penedo, J. C. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-32189-9_11 · Cited by 8
“It was found that ribocil treatment of infected mice reduced the concentration of pathogenic bacteria by more than 1000-fold (Hermann 2015; Howe et al. 2015).”
BackgroundWakchaure, P. D., & Ganguly, B. (2021) · Physical Chemistry Chemical Physics · doi:10.1039/d1cp01348c · Cited by 7
Developing New Tools to Fight Human Pathogens: A Journey through the Advances in RNA Technologies
Costa, V., Costa, S. M., Saramago, M., Cunha, M. V., Arraiano, C. M., Viegas, S. C., & Matos, R. G. (2022) · Microorganisms · doi:10.3390/microorganisms10112303 · Cited by 9
Plowright, A. T., & Drowley, L. (2017) · Annual reports in medicinal chemistry · doi:10.1016/bs.armc.2017.07.001 · Cited by 11
Going on offense against the gram-negative defense
Drown, B., & Hergenrother, P. J. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1807278115 · Cited by 7
NMR chemical shift assignments of RNA oligonucleotides to expand the RNA chemical shift database
Liu, Y., Kotar, A., Hodges, T. L., Abdallah, K., Taleb, M. H., Bitterman, B. A., Jaime, S., Schaubroeck, K. J., Mathew, E., Morgenstern, N. W., et al. (2021) · Biomolecular NMR Assignments · doi:10.1007/s12104-021-10049-0 · Cited by 8
Higo, J., Bekker, G., Kamiya, N., Fukuda, I., & Fukunishi, Y. (2023) · Biophysics and Physicobiology · doi:10.2142/biophysico.bppb-v20.0047 · Cited by 6
Adenine Methylation Enhances the Conformational Flexibility of an RNA Hairpin Tetraloop
Levintov, L., & Vashisth, H. (2024) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.4c00522 · Cited by 6
Restoration of Ribozyme Tertiary Contact and Function by Using a Molecular Glue for RNA
Dohno, C., Kimura, M., & Nakatani, K. (2017) · Angewandte Chemie · doi:10.1002/ange.201709041 · Cited by 6
Balibar, C. J., Villafania, A., Barbieri, C. M., Murgolo, N., Roemer, T., Wang, H., & Howe, J. A. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7847-2_2 · Cited by 6
Self-citationWakchaure, P. D., Jana, K., & Ganguly, B. (2019) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2019.1665587 · Cited by 6
Stereoselective RNA reaction with chiral 2′-OH acylating agents
Shioi, R., Xiao, L., Chatterjee, S., & Kool, E. T. (2023) · Chemical Science · doi:10.1039/d3sc03067a · Cited by 8
Self-citationCheng, S.-Q., Su, X.-X., Wang, X.-N., Sun, Z.-Y., & Ou, T. (2019) · Methods · doi:10.1016/j.ymeth.2019.06.004 · Cited by 6
Zhang, X., Zhou, K., Mao, X., Xiong, Y., & Ren, J. (2025) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2025.117578 · Cited by 5
Mechanistic studies of small molecule ligands selective to RNA single G bulges
Hegde, S., Akhter, S., Tang, Z., Qi, C., Yu, C., Lewicka, A., Liu, Y., Koirala, K., Reibarkh, M., Battaile, K. P., et al. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf559 · Cited by 7
Knotty is nice: Metabolite binding and RNA-mediated gene regulation by the preQ1 riboswitch family
Kiliushik, D., Goenner, C., Law, M., Schroeder, G. M., Srivastava, Y., Jenkins, J. L., & Wedekind, J. E. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107951 · Cited by 6
Small-molecule RNA ligands: a patent review (2018–2024)
Ravegnini, E., Trabocchi, A., & Lenci, E. (2025) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2025.2492759 · Cited by 6
“Also, Ribocil B is a tight binder to the flavin mononucleotide (FMN) riboswitch, which impedes the natural binding of FMN and blocks the riboflavin biosynthetic pathway, thus displaying antibiotic activity against Gram-negative bacteria [22].”
Rivera, M., Ayon, O. S., Diaconescu-Grabari, S., Pottel, J., Moitessier, N., Mittermaier, A., & McKeague, M. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae118 · Cited by 7
“These results support the use of these FMN analogues as antimetabolites and inhibitors that target the FMN riboswitch and exert antibacterial effects ( 17 ).”
BackgroundResultWang, H., Cai, L., Wang, H., Xu, X., & Zhou, G. (2019) · LWT · doi:10.1016/j.lwt.2019.05.097 · Cited by 5
Self-citationDevelopment of a fully automated platform for agar-based measurement of viable bacterial growth
Squadroni, B., Newhard, W., Carr, D. M., Trinh, H., Racine, F., Zuck, P. D., Howell, B. J., Hazuda, D. J., & Cassaday, J. (2022) · SLAS TECHNOLOGY · doi:10.1016/j.slast.2022.03.003 · Cited by 5
Self-citationBekker, G., Fukunishi, Y., Higo, J., & Kamiya, N. (2024) · ACS Omega · doi:10.1021/acsomega.3c06826 · Cited by 5
Deb, I., Wong, H., Tacubao, C., & Frank, A. T. (2021) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.1c02702 · Cited by 5
Antibiotics: Precious Goods in Changing Times
Saß, P. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2855-3_1 · Cited by 7
The kinase inhibitor Palbociclib is a potent and specific RNA-binding moleculePreprint
Shortridge, M. D., Vidalala, V., & Varani, G. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.20.477126 · Cited by 5
Fullenkamp, C. R., Liang, X., Pettersson, M., & Schneekloth, J. S. (2024) · Methods and principles in medicinal chemistry · doi:10.1002/9783527840458.ch13 · Cited by 5
Gao, J., Chen, Z., Zeng, C., Liu, H., & Zhao, Y. (2025) · Pharmaceuticals · doi:10.3390/ph18101593 · Cited by 5
“The success of Ribocil provided cellular proof that small molecule binding to a non-coding RNA structural element is sufficient to elicit antibacterial activity [14–16].”
Skudlarek, J. W., Cooke, A., Mitchell, H. J., Babaoglu, K., Shaw, A. W., Tong, L., Nomland, A. B., Labroli, M. A., Sha, D., Mulhearn, J. J., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c01277 · Cited by 4
Self-citationThree-dimensional structure of the palbociclib–HIV TAR complex
Ramireddy, R. R., Vidalala, V., Chaubey, B., Olsen, G. L., & Varani, G. (2026) · Nucleic Acids Research · doi:10.1093/nar/gkag129 · Cited by 4
Classification of riboswitch sequences using k-mer frequencies
Guillen-Ramirez, H., & Martínez-Pérez, I. (2018) · Biosystems · doi:10.1016/j.biosystems.2018.09.001 · Cited by 4
Method for Identifying Sequence Motifs in Pre-miRNAs for Small-Molecule Binding
Takashima, Y., Murata, A., Iida, K., Sugai, A., Hagiwara, M., & Nakatani, K. (2022) · ACS Chemical Biology · doi:10.1021/acschembio.2c00452 · Cited by 5
Eschbach, S. H., Hien, E. D. M., Ghosh, T., Lamontagne, A.-M., & Lafontaine, D. A. (2024) · RNA · doi:10.1261/rna.080074.124 · Cited by 4
“…molecules targeting the FMN ribos-witch (Lee et al. 2009; Ott et al. 2009; Long et al. 2010; Mansjö and Johansson 2011; Blount et al. 2015; Howe et al. 2015; Matern et al. 2016; Wang et al. 2017; Vicens et al. 2018; Motika et al. 2020), which make this riboswitch a prime candidate for the…”
Sharma, A., Gopi, P., Trivedi, R., Kumar, D., Gartia, J., Babu, A. R. S., Pandya, P., Singh, G., & Barnwal, R. P. (2025) · Biochimie · doi:10.1016/j.biochi.2025.07.017 · Cited by 4
Identifizierung des Schlüsselenzyms der Roseoflavinbiosynthese
Schwarz, J., Konjik, V., Jankowitsch, F., Sandhoff, R., & Mack, M. (2016) · Angewandte Chemie · doi:10.1002/ange.201600581 · Cited by 4
A click chemistry assay to identify natural product ligands for pre-microRNAs
Garner, A. L., Lorenz, D. A., & Gallagher, E. E. (2019) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2019.04.020 · Cited by 4
“Key examples from the discovery of ribocil, a synthetic ligand for the FMN riboswitch (Howe et al., 2015), and RNA-binding SMN-C and NVS-SM1 SMN2 splicing modulators (Naryshkin et al., 2014; Palacino et al., 2015; Sivaramakrishnan et al., 2017), have provided recent evidence for the potential…”
Background
Metadata
- Authors
- Howe, J. A., Wang, H., Fischmann, T. O., Balibar, C. J., Xiao, L., Galgoci, A. M., Malinverni, J. C., Mayhood, T., Villafania, A., Nahvi, A., Murgolo, N., Barbieri, C. M., Mann, P. A., Carr, D., Xia, E., Zuck, P., Riley, D., Painter, R. E., Walker, S. S., Sherborne, B., de Jesus, R., Pan, W., Plotkin, M. A., Wu, J., Rindgen, D., Cummings, J., Garlisi, C. G., Zhang, R., Sheth, P. R., Gill, C. J., Tang, H., & Roemer, T.
- Affiliations
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- Corresponding author
- Roemer, Terry
- ORCID
- Venue
- Nature
- Published
- 2015-09-30
- Volume
- 526
- Issue
- 7575
- Pages
- 672-677
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1931081986
- Cited by
- 407
- References
- 55
- Citations by year
- 2026: 15 · 2025: 40 · 2024: 43 · 2023: 34 · 2022: 38 · 2021: 35 · 2020: 39 · 2019: 43 · 2018: 42 · 2017: 40 · 2016: 35 · 2015: 2
- FWCI
- 17.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Institute of Microbiology, Chinese Academy of Sciences
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA modifications and cancer
- Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis
- Keywords
- riboswitches, flavin mononucleotide, non-coding RNA, riboflavin biosynthesis, antibiotic discovery, phenotypic screening
- MeSH terms
- Animals, Bacteria, Base Sequence, Escherichia coli Infections, Female, Flavin Mononucleotide, Heat-Shock Proteins, Ligands, Mice, Inbred DBA, Models, Molecular, Molecular Sequence Data, Pyrimidines, Riboflavin, RNA, Bacterial, Substrate Specificity, Reproducibility of Results, Gene Expression Regulation, Bacterial, Crystallography, X-Ray, Intramolecular Transferases, Escherichia coli Proteins, Mice, Aptamers, Nucleotide, Riboswitch
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.